Volenrelaxin

DB21750InvestigationalProtein Based Therapies

Volenrelaxin is under investigation in clinical trial NCT06598631 (Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease).

Mechanism
Curator reviewed
Code names
LY-3540378

Resolves to

Compound
UNIITVT9XLV5MUCAS2653949-19-8
Targets
Q9HBX9RXFP1

What you can answer from here — as of October 22, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Volenrelaxin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In